• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathologic Complete Response After Chemoradiation of a Massive Primary Urethral Carcinoma.

作者信息

Singh Tanmay, Li Qing Kay, Song Daniel Y

机构信息

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

出版信息

Adv Radiat Oncol. 2019 Mar 14;4(3):487-491. doi: 10.1016/j.adro.2019.02.005. eCollection 2019 Jul-Sep.

DOI:10.1016/j.adro.2019.02.005
PMID:31360804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6639762/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad03/6639762/d32ecaa08c13/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad03/6639762/ed03bdad1586/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad03/6639762/d32ecaa08c13/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad03/6639762/ed03bdad1586/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad03/6639762/d32ecaa08c13/gr2.jpg

相似文献

1
Pathologic Complete Response After Chemoradiation of a Massive Primary Urethral Carcinoma.巨大原发性尿道癌放化疗后的病理完全缓解
Adv Radiat Oncol. 2019 Mar 14;4(3):487-491. doi: 10.1016/j.adro.2019.02.005. eCollection 2019 Jul-Sep.
2
CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.CEA-预测直肠癌新辅助治疗后病理完全缓解的指标。
Dis Colon Rectum. 2013 Jul;56(7):859-68. doi: 10.1097/DCR.0b013e31828e5a72.
3
Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra.同步放化疗联合保留生殖器治疗男性尿道原发性浸润癌。
J Urol. 2008 Feb;179(2):536-41; discussion 541. doi: 10.1016/j.juro.2007.09.068.
4
Neoadjuvant Radiation with Concurrent 5-FU Resulting in Complete Pathologic Response in Stage IIIB Squamous Cell Carcinoma of the Urethra.新辅助放疗联合5-氟尿嘧啶治疗ⅢB期尿道鳞状细胞癌获完全病理缓解
Case Rep Oncol Med. 2020 Feb 14;2020:7948538. doi: 10.1155/2020/7948538. eCollection 2020.
5
T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.晚期直肠癌术前放化疗后T分期降期和完全病理缓解可降低复发率并提高无病生存率。
Dis Colon Rectum. 2002 Jul;45(7):895-903. doi: 10.1007/s10350-004-6325-7.
6
Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC.可切除的局部晚期非小细胞肺癌放化疗反应的放射学与病理学相关性
Lung Cancer. 2016 Dec;102:1-8. doi: 10.1016/j.lungcan.2016.10.002. Epub 2016 Oct 14.
7
Combined chemoradiation as primary treatment for invasive male urethral cancer.联合放化疗作为原发性侵袭性男性尿道癌的治疗方法。
J Urol. 2015 Feb;193(2):532-7. doi: 10.1016/j.juro.2014.07.105. Epub 2014 Aug 1.
8
Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?食管腺鳞癌应按腺癌还是鳞癌治疗？
J Surg Oncol. 2020 Sep;122(3):412-421. doi: 10.1002/jso.25990. Epub 2020 May 27.
9
Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified?直肠癌术前放化疗后的完全临床缓解：“观察等待”策略是否合理？
Dis Colon Rectum. 2008 Jan;51(1):10-9; discussion 19-20. doi: 10.1007/s10350-007-9080-8. Epub 2007 Nov 28.
10
Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.黏液组织学对直肠癌中基于卡培他滨的新辅助放化疗后病理完全缓解率的预测意义：一项对比研究
J Gastrointest Cancer. 2019 Dec;50(4):716-722. doi: 10.1007/s12029-018-0136-x.

引用本文的文献

1
Neoadjuvant Radiation with Concurrent 5-FU Resulting in Complete Pathologic Response in Stage IIIB Squamous Cell Carcinoma of the Urethra.新辅助放疗联合5-氟尿嘧啶治疗ⅢB期尿道鳞状细胞癌获完全病理缓解
Case Rep Oncol Med. 2020 Feb 14;2020:7948538. doi: 10.1155/2020/7948538. eCollection 2020.

本文引用的文献

1
Patient autonomy and shared decision making in the management of urethral cancer.尿道癌管理中的患者自主权与共同决策
Pract Radiat Oncol. 2016 Jan-Feb;6(1):66-70. doi: 10.1016/j.prro.2015.09.002. Epub 2015 Sep 12.
2
Combined chemoradiation as primary treatment for invasive male urethral cancer.联合放化疗作为原发性侵袭性男性尿道癌的治疗方法。
J Urol. 2015 Feb;193(2):532-7. doi: 10.1016/j.juro.2014.07.105. Epub 2014 Aug 1.
3
Quality of life for patients treated for penile cancer.阴茎癌患者的生活质量。
J Urol. 2014 Oct;192(4):1105-10. doi: 10.1016/j.juro.2014.04.014. Epub 2014 Apr 18.
4
Management of advanced primary urethral carcinomas.原发性尿道高级别癌的治疗。
BJU Int. 2014 Jul;114(1):25-31. doi: 10.1111/bju.12630. Epub 2014 May 22.
5
Squamous cell carcinoma of the bulbar urethra.球部尿道鳞状细胞癌
J Clin Oncol. 2011 Oct 1;29(28):e733-5. doi: 10.1200/JCO.2011.36.5890. Epub 2011 Aug 29.
6
Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra.同步放化疗联合保留生殖器治疗男性尿道原发性浸润癌。
J Urol. 2008 Feb;179(2):536-41; discussion 541. doi: 10.1016/j.juro.2007.09.068.
7
Incidence of primary urethral carcinoma in the United States.美国原发性尿道癌的发病率。
Urology. 2006 Dec;68(6):1164-8. doi: 10.1016/j.urology.2006.08.1057. Epub 2006 Dec 4.
8
Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy.
Int J Urol. 2004 Aug;11(8):678-82. doi: 10.1111/j.1442-2042.2004.00859.x.
9
Male urethral carcinoma: analysis of treatment outcome.男性尿道癌：治疗结果分析
Urology. 1999 Jun;53(6):1126-32. doi: 10.1016/s0090-4295(98)00659-1.
10
Management of primary urethral cancer.原发性尿道癌的管理
Urology. 1998 Sep;52(3):487-93. doi: 10.1016/s0090-4295(98)00199-x.